Incomplete multiresponse designs and surrogate endpoints in clinical trials
نویسندگان
چکیده
منابع مشابه
Multiresponse Designs and Surrogate Endpoints in Clinical Trials
Incorporating plausible surrogate variates, a general class of incomplete multiresponse designs for clinical trials is considered. In this context, the basic differences between the conventional linear models and survival analysis models are discussed thoroughly. Along with some parametric and semi-parametric procedures, suitable nonparametric ones are considered, and the related asymptotic the...
متن کاملBiomarkers and surrogate endpoints in clinical trials.
One of the most important considerations in designing clinical trials is the choice of outcome measures. These outcome measures could be clinically meaningful endpoints that are direct measures of how patients feel, function, and survive. Alternatively, indirect measures, such as biomarkers that include physical signs of disease, laboratory measures, and radiological tests, often are considered...
متن کاملDefining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria
BACKGROUND Clinical trials in severe falciparum malaria require a large sample size to detect clinically meaningful differences in mortality. This means few interventions can be evaluated at any time. Using a validated surrogate endpoint for mortality would provide a useful alternative allowing a smaller sample size. Here we evaluate changes in coma score and plasma lactate as surrogate endpoin...
متن کاملTitle Evaluation of Surrogate Endpoints in Clinical Trials
May 15, 2015 Type Package Title Evaluation of Surrogate Endpoints in Clinical Trials Version 0.1-6 Date 2015-05-14 Author Wim Van der Elst, Ariel Alonso & Geert Molenberghs Maintainer Wim Van der Elst Description In a clinical trial, it frequently occurs that the most credible outcome to evaluate the effectiveness of a new therapy (the true endpoint) is difficult to m...
متن کاملAdaptive designs for clinical trials with multiple endpoints
Rationale for adaptive designs with multiple endpoints In clinical trials, the efficacy of a new treatment is usually assessed by a single primary endpoint [1,2]. Other important aspects concerning the new treatment, such as adverse events or quality of life, are taken into account by the definition of secondary endpoints. Usually, only the primary endpoint is analyzed confirmatorily with a sta...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Statistical Planning and Inference
سال: 1994
ISSN: 0378-3758
DOI: 10.1016/0378-3758(94)90195-3